U.S. advances first government-funded trials of psychedelic drug ibogaine

US advances first government-funded trials of psychedelic drug ibogaine - Regional Media News

By Kamal Choudhury Oct 5 (Reuters) - US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, the FDA said on Monday, as it sought public feedback on safety rules for the studies. The initiative follows an April executive order by President Donald Trump, dedicating $50 million to the federal ibogaine research, as well as recent cal…

First Government-Funded Psychedelic Drug Trial

U.S. advances first government-funded trials of psychedelic drug ibogaine

U.S. health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder.

US advances first government-funded trials of psychedelic drug ibogaine

Oct 5 (Reuters) - US health officials are advancing the first government-funded clinical trials of the psychedelic drug ibogaine to treat opioid addiction and post-traumatic stress disorder, ​the FDA said on Monday, as it sought ‌public feedback on saf...

FDA Seeks Public Input On Psychedelic Research Involving Ibogaine

The Food and Drug Administration (FDA) is seeking public input on how to design research on the potential therapeutic benefits of the psychedelic ibogaine. The agency’s request for information (RFI), released on Monday, seeks comments and data in four main areas: General study design, including appropriate patient populations; Dose selection and escalation, including the proposed […]